Founded in 2009, Mission Bay Capital focuses on making early-stage investments in bioscience companies emerging from the University of California. The firm combines the expertise of QB3 executives with the guidance of an experienced investment advisory committee. Mission Bay Capital aims to help launch companies that address societal needs in areas such as genetics and pharmaceuticals. The firm typically invests in rounds with 5-6 participants and has been involved in 2-6 deals per year. Some of its notable portfolio startups include Alector, Bolt Threads, and Caribou Biosciences.